# Endovascular Repair With In Situ nEedle feNestration of Left Subclavian Artery to Treat AoRtic Dissection(RISEN STAR):A Multicenter Prospective Trial.

> **NCT05186181** · — · UNKNOWN · sponsor: **First Affiliated Hospital of Zhejiang University** · enrollment: 217 (estimated)

## Conditions studied

- Aortic Dissection
- Left Subclavian Artery Occlusion
- Vascular Diseases
- Interventional Therapy

## Interventions

- **BEHAVIORAL:** In situ fenestration

## Key facts

- **NCT ID:** NCT05186181
- **Lead sponsor:** First Affiliated Hospital of Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-01
- **Primary completion:** 2024-01
- **Final completion:** 2025-12
- **Target enrollment:** 217 (ESTIMATED)
- **Last updated:** 2023-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05186181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05186181, "Endovascular Repair With In Situ nEedle feNestration of Left Subclavian Artery to Treat AoRtic Dissection(RISEN STAR):A Multicenter Prospective Trial.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05186181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*